Home Cart 0 Sign in  
X

[ CAS No. 32857-62-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 32857-62-8
Chemical Structure| 32857-62-8
Chemical Structure| 32857-62-8
Structure of 32857-62-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 32857-62-8 ]

Related Doc. of [ 32857-62-8 ]

Alternatived Products of [ 32857-62-8 ]

Product Details of [ 32857-62-8 ]

CAS No. :32857-62-8 MDL No. :MFCD00004352
Formula : C9H7F3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :HNORVZDAANCHAY-UHFFFAOYSA-N
M.W : 204.15 Pubchem ID :118342
Synonyms :

Calculated chemistry of [ 32857-62-8 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.99
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.55
Log Po/w (XLOGP3) : 2.45
Log Po/w (WLOGP) : 3.48
Log Po/w (MLOGP) : 2.7
Log Po/w (SILICOS-IT) : 2.59
Consensus Log Po/w : 2.55

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.77
Solubility : 0.348 mg/ml ; 0.0017 mol/l
Class : Soluble
Log S (Ali) : -2.88
Solubility : 0.271 mg/ml ; 0.00133 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.07
Solubility : 0.175 mg/ml ; 0.000855 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.33

Safety of [ 32857-62-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 32857-62-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 32857-62-8 ]
  • Downstream synthetic route of [ 32857-62-8 ]

[ 32857-62-8 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 32857-62-8 ]
  • [ 1891-90-3 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 2, p. 624 - 627
  • 2
  • [ 67-56-1 ]
  • [ 32857-62-8 ]
  • [ 52787-14-1 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 43, p. 7731 - 7734
  • 3
  • [ 124-38-9 ]
  • [ 939-99-1 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 4, p. 1221 - 1224
[2] Chemical Communications, 2002, # 23, p. 2798 - 2799
  • 4
  • [ 124-38-9 ]
  • [ 189096-91-1 ]
  • [ 32857-62-8 ]
Reference: [1] Chemical Science, 2018, vol. 9, # 21, p. 4873 - 4878
  • 5
  • [ 512787-33-6 ]
  • [ 32857-62-8 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 50, p. 9925 - 9932
  • 6
  • [ 1436389-36-4 ]
  • [ 62037-86-9 ]
  • [ 32857-62-8 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 11, p. 2648 - 2651
  • 7
  • [ 135325-18-7 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 1, p. 445 - 447
  • 8
  • [ 124-38-9 ]
  • [ 939-99-1 ]
  • [ 6140-17-6 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of the Chemical Society - Dalton Transactions, 1996, # 8, p. 1613 - 1618
[2] Journal of the Chemical Society - Dalton Transactions, 1996, # 8, p. 1613 - 1618
  • 9
  • [ 455-13-0 ]
  • [ 64-19-7 ]
  • [ 32857-62-8 ]
Reference: [1] ChemCatChem, 2014, vol. 6, # 6, p. 1589 - 1593
  • 10
  • [ 1436389-42-2 ]
  • [ 62037-86-9 ]
  • [ 32857-62-8 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 11, p. 2648 - 2651
  • 11
  • [ 1798-06-7 ]
  • [ 62037-86-9 ]
  • [ 32857-62-8 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 11, p. 2648 - 2651
  • 12
  • [ 1436389-45-5 ]
  • [ 62037-86-9 ]
  • [ 32857-62-8 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 11, p. 2648 - 2651
  • 13
  • [ 2338-75-2 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
[2] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
  • 14
  • [ 133604-88-3 ]
  • [ 32857-62-8 ]
  • [ 108-68-9 ]
Reference: [1] Journal of the American Chemical Society, 1991, vol. 113, # 9, p. 3451 - 3458
  • 15
  • [ 349-95-1 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
[2] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
  • 16
  • [ 939-99-1 ]
  • [ 32857-62-8 ]
Reference: [1] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
[2] Journal of pharmaceutical sciences, 1973, vol. 62, # 6, p. 910 - 913
  • 17
  • [ 455-19-6 ]
  • [ 32857-62-8 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 50, p. 9925 - 9932
  • 18
  • [ 131356-53-1 ]
  • [ 32857-62-8 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 50, p. 9925 - 9932
  • 19
  • [ 74426-51-0 ]
  • [ 32857-62-8 ]
Reference: [1] Canadian Journal of Chemistry, 1992, vol. 70, # 3, p. 992 - 999
  • 20
  • [ 455-14-1 ]
  • [ 32857-62-8 ]
Reference: [1] Patent: CN107417509, 2017, A,
  • 21
  • [ 67-56-1 ]
  • [ 143659-29-4 ]
  • [ 32857-62-8 ]
  • [ 5903-23-1 ]
Reference: [1] Canadian Journal of Chemistry, 1992, vol. 70, # 3, p. 992 - 999
[2] Canadian Journal of Chemistry, 1992, vol. 70, # 3, p. 992 - 999
  • 22
  • [ 32857-62-8 ]
  • [ 2968-93-6 ]
YieldReaction ConditionsOperation in experiment
100% With borane dimethyl sulfide complex In tetrahydrofuran at 20℃; Borane dimethylsulfide complex (2M in THF, 6.9 ml, 13.8 mmol) was added slowly to a solution of the appropriate phenylacetic acid (10.6 mmol) in THF (20 ml) at room temperature. The reaction was stirred overnight before being quenched by the slow addition of sodium hydroxide (2N, 20ml). The mixture was stirred at room temperature for 1 h then extracted with ethyl acetate (2 x 50 ml). The organic layers were dried overMgS04 and condensed to give the appropriate alcohol as an oil (quantitative). Phosphorous tribromide (0.50 ml, 1.4 g, 5.3 mmol) was added to the neat alcohol whilst stirring in a room temperature water bath. The reaction was then heated to 100 C for 2 h until evolution of HBr ceased. The reaction was cooled and added dropwise to an ice/water mixture. The product was extracted twice with hexane and the combined organic layers washed with saturated sodium carbonate solution. The organic layer was dried <Desc/Clms Page number 49>over MgS04 and condensed to give the desired bromide which was used without further purification. The following alkyl bromides were made according to the general procedure described in Description30 : 1-(2-bromoethyl)-4-trifluoromethylbenzene ; 1-(2-bromoethyl) -2, 4-dichlorobenzene ; 1- (2-bromoethyl)-2-fluoro-4-trifluoromethylbenzene 4-(2-bromoethyl)-2-fluoro-1-trifluoromethylbenzene; 1-(2bromoethyl)-2-chloro-4-trifluoromethylbenzene; 1-(2-bromoethyl)-3chlorobenzene. 3-bromomethyl-6-chloro-1-benzothiophene was prepared according to Magn. Reson. Chem. 1985,23, 10,814.
100%
Stage #1: With borane-THF In tetrahydrofuran at 20℃; for 16 h;
Stage #2: With sodium hydroxide In tetrahydrofuran; water for 1 h;
A solution of Borane in tetrahydrofuran (1.0 M, 14.6 ml, 14.6 mmol) was added slowly to a solution of [4-(trifluoromethyl)phenyl]acetic acid (2.5 g, 11.3 mmol) in tetrahydrofuran (15 ml) in a water bath at room temperature. The reaction was stirred at room temperature for 16 h. The reaction was quenched by the addition of sodium hydroxide solution (2 M, 25 ml) and stirred for 1 h. The reaction was extracted with ethyl acetate (2 x 100 ml) and the organic layers dried over MgSO4 and condensed to give the title compound which was used without further purification (2.2 g, quant.). 1H NMR (360 MHz, CDCl3) δ 7.57 (2 H, d, J8.0), 7.35 (2 H, d, J7.9), 3.90 (2 H, t, J6.5), 2.93 (2 H, t, J6.5).
92%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃;
Stage #2: With hydrogenchloride; water In tetrahydrofuranCooling with ice
Example 60A
2-(4-Trifluoromethylphenyl)ethanol
3.0 g (14.7 mmol) of 4-trifluoromethylphenylacetic acid are introduced into 30 ml of abs. THF at 0° C. A 1 M solution of 557.8 mg (14.7 mmol) of lithium aluminum hydride in 14.7 ml of THF is added dropwise, and the solution is stirred at room temperature until reaction is complete.
The mixture is added to ice, acidified with hydrochloric acid and extracted with ethyl acetate.
The organic phase is concentrated, and the crude product is purified by chromatography on silica gel (mobile phase: cyclohexane/ethyl acetate 6:1).
2 g (92percent of theory) of the title compound are obtained.
1H-NMR (400 MHz, CDCl3, δ/ppm): 2.95 (t, 2H), 3.9 (t, 2H), 7.35 (d, 2H), 7.6 (t, 2H).
92% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; Example 1A
2-(4-Trifluoromethylphenyl)ethanol
3.0 g (14.7 mmol) of 4-trifluoromethylphenylacetic acid are introduced into 30 ml of abs. THF at 0° C., then a 1 M solution of 557 mg (14.7 mmol) of lithium aluminum hydride in 14.7 ml of THF is added dropwise, and the solution is stirred at room temperature until reaction is complete.
The mixture is added to ice, acidified with hydrochloric acid and extracted with ethyl acetate.
The organic phase is concentrated, and the crude product is purified by chromatography on silica gel. 2 g (92percent of theory) of the title compound are obtained.
1H-NMR (400 MHz, CDCl3, δ/ppm): 2.95 (t, 2H), 3.9 (t, 2H), 7.35 (d, 2H), 7.6 (t, 2H).
85% With borane-THF In tetrahydrofuran at 20℃; for 16 h; Step i: 2-(4-(trifluoromethyl)phenyl)ethanol
To a 500 mL round bottom flask, were added 2-(4-(trifluoromethyl)phenyl)acetic acid (10 g, 0.049 mol) and THF (90 mL) . To the same flask, 1.0 M borane tetrahydrofuran complex (54 mL, 0.054 mol) was added at room temperature. The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was quenched with 2.0 N aqueous sodium hydroxide (145 mL) and stirred at room temperature for 1 h. The reaction mixture was extracted with ethyl acetate. The organic layer was separated, washed with brine and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to get the title compound [7.9 g, 85 percent]. NMR (300 MHz, CDC13): δ 7.58 (d, 2H), 7.36 (d, 2H), 3.91 (t, 2H), 3.91 (t, 2H).
80% With borane In tetrahydrofuran at 0 - 20℃; for 2.75 h; Part A:
Preparation of 2-(4-Trifluoromethylphenyl)-ethanol
A solution of 4-trifluoromethylphenylacetic acid (784 mg, 3.84 mmol) in tetrahydrofuran (3 mL) was cooled to 0° C. and treated dropwise with a solution of borane in tetrahydrofuran (1.0 M, 5.4 mL, 5.4 mmol).
The mixture was stirred at room temperature for 2.75 hours, then was treated slowly with 50percent water in tetrahydrofuran (2 mL), followed by water (2 mL).
The mixture was stirred for 5 minutes, and solid potassium carbonate was added to saturate the aqueous phase.
The layers were separated and the aqueous phase was extracted with ethyl acetate.
The combined organic phases were dried over sodium sulfate and concentrated under vacuum to provide a colorless liquid (585 mg, 80percent) which was used without further purification. 1H NMR (300 MHz, CDCl3) δ 7.59 (d, J=8 Hz, 2H), 7.38 (d, J=8 Hz, 2H), 3.92 (t, J=7 Hz, 2H), 2.95 (t, J=7 Hz, 2H), 1.53 (s, 1H).

Reference: [1] Patent: WO2005/49613, 2005, A1, . Location in patent: Page/Page column 48-49
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 35, p. 5803 - 5806
[3] Patent: WO2006/120481, 2006, A2, . Location in patent: Page/Page column 19
[4] Patent: US2009/227640, 2009, A1, . Location in patent: Page/Page column 49
[5] Patent: US2009/291993, 2009, A1, . Location in patent: Page/Page column 12; 21
[6] Patent: WO2015/101928, 2015, A1, . Location in patent: Page/Page column 127;
[7] Patent: US2004/67935, 2004, A1, . Location in patent: Page/Page column 30
[8] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 3, p. 756 - 760
[9] Journal of Medicinal Chemistry, 1998, vol. 41, # 3, p. 358 - 378
[10] Journal of Medicinal Chemistry, 2002, vol. 45, # 19, p. 4321 - 4335
[11] Journal of Organic Chemistry, 2014, vol. 79, # 24, p. 11988 - 12003
[12] Chemistry - A European Journal, 2015, vol. 21, # 7, p. 2785 - 2788
[13] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 2, p. 131 - 134
  • 23
  • [ 64-17-5 ]
  • [ 32857-62-8 ]
  • [ 721-63-1 ]
Reference: [1] Chemical Communications, 2018, vol. 54, # 26, p. 3231 - 3234
[2] Organic and Biomolecular Chemistry, 2018, vol. 16, # 41, p. 7574 - 7578
[3] Chemical Communications, 2015, vol. 51, # 84, p. 15446 - 15449
[4] Journal of Organic Chemistry, 2016, vol. 81, # 24, p. 12116 - 12127
[5] Journal of the American Chemical Society, 2013, vol. 135, # 2, p. 620 - 623
[6] Patent: US2013/253204, 2013, A1, . Location in patent: Paragraph 0255; 0256; 0257
[7] Patent: WO2016/49099, 2016, A1, . Location in patent: Page/Page column 122
[8] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 17, p. 3876 - 3886
[9] Patent: WO2008/76427, 2008, A2, . Location in patent: Page/Page column 66
  • 24
  • [ 7664-93-9 ]
  • [ 32857-62-8 ]
  • [ 721-63-1 ]
Reference: [1] Patent: US5656629, 1997, A,
  • 25
  • [ 32857-62-8 ]
  • [ 721-63-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 12, p. 1193 - 1198
  • 26
  • [ 32857-62-8 ]
  • [ 130365-87-6 ]
Reference: [1] Canadian Journal of Chemistry, 1996, vol. 74, # 3, p. 453 - 456
[2] Patent: WO2015/101928, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 32857-62-8 ]

Fluorinated Building Blocks

Chemical Structure| 3038-48-0

[ 3038-48-0 ]

2-(Trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 177952-39-5

[ 177952-39-5 ]

2,4-Bis(trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 53473-36-2

[ 53473-36-2 ]

4-(Trifluoromethyl)hydrocinnamic acid

Similarity: 0.93

Chemical Structure| 585-50-2

[ 585-50-2 ]

3-(3-(Trifluoromethyl)phenyl)propanoic acid

Similarity: 0.93

Chemical Structure| 94022-99-8

[ 94022-99-8 ]

3-[2-(Trifluoromethyl)phenyl]propanoic acid

Similarity: 0.91

Aryls

Chemical Structure| 3038-48-0

[ 3038-48-0 ]

2-(Trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 177952-39-5

[ 177952-39-5 ]

2,4-Bis(trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 53473-36-2

[ 53473-36-2 ]

4-(Trifluoromethyl)hydrocinnamic acid

Similarity: 0.93

Chemical Structure| 585-50-2

[ 585-50-2 ]

3-(3-(Trifluoromethyl)phenyl)propanoic acid

Similarity: 0.93

Chemical Structure| 94022-99-8

[ 94022-99-8 ]

3-[2-(Trifluoromethyl)phenyl]propanoic acid

Similarity: 0.91

Carboxylic Acids

Chemical Structure| 3038-48-0

[ 3038-48-0 ]

2-(Trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 177952-39-5

[ 177952-39-5 ]

2,4-Bis(trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 53473-36-2

[ 53473-36-2 ]

4-(Trifluoromethyl)hydrocinnamic acid

Similarity: 0.93

Chemical Structure| 585-50-2

[ 585-50-2 ]

3-(3-(Trifluoromethyl)phenyl)propanoic acid

Similarity: 0.93

Chemical Structure| 94022-99-8

[ 94022-99-8 ]

3-[2-(Trifluoromethyl)phenyl]propanoic acid

Similarity: 0.91

Trifluoromethyls

Chemical Structure| 3038-48-0

[ 3038-48-0 ]

2-(Trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 177952-39-5

[ 177952-39-5 ]

2,4-Bis(trifluoromethyl)phenylacetic acid

Similarity: 0.96

Chemical Structure| 53473-36-2

[ 53473-36-2 ]

4-(Trifluoromethyl)hydrocinnamic acid

Similarity: 0.93

Chemical Structure| 585-50-2

[ 585-50-2 ]

3-(3-(Trifluoromethyl)phenyl)propanoic acid

Similarity: 0.93

Chemical Structure| 94022-99-8

[ 94022-99-8 ]

3-[2-(Trifluoromethyl)phenyl]propanoic acid

Similarity: 0.91